FDA Inspection 793461 — Hisun Pharmaceutical Hangzhou Co., Ltd

Hisun Pharmaceutical Hangzhou Co., Ltd — FEI 3008481334

The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on July 6, 2012 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 6, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hangzhou (China)